These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 21166594)
61. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Cassatella MA; Gasperini S; Bovolenta C; Calzetti F; Vollebregt M; Scapini P; Marchi M; Suzuki R; Suzuki A; Yoshimura A Blood; 1999 Oct; 94(8):2880-9. PubMed ID: 10515892 [TBL] [Abstract][Full Text] [Related]
63. Calcipotriol inhibits proliferation of human keratinocytes by downregulating STAT1 and STAT3 signaling. Liang W; Lin Z; Zhang L; Qin X; Zhang Y; Sun L J Investig Med; 2017 Feb; 65(2):376-381. PubMed ID: 28130440 [TBL] [Abstract][Full Text] [Related]
64. Upregulation of gp130 and differential activation of STAT and p42/44 MAPK in the rat hippocampus following kainic acid-induced seizures. Choi JS; Kim SY; Park HJ; Cha JH; Choi YS; Kang JE; Chung JW; Chun MH; Lee MY Brain Res Mol Brain Res; 2003 Nov; 119(1):10-8. PubMed ID: 14597225 [TBL] [Abstract][Full Text] [Related]
65. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. Stancato LF; David M; Carter-Su C; Larner AC; Pratt WB J Biol Chem; 1996 Feb; 271(8):4134-7. PubMed ID: 8626752 [TBL] [Abstract][Full Text] [Related]
66. Phosphorylation of signal transducer and activator of transcription 6 (STAT6) and STAT1, but not STAT3, induced by antigen inhalation in bronchial smooth muscles of sensitized mice. Chiba Y; Todoroki M; Misawa M Biol Pharm Bull; 2010; 33(1):146-9. PubMed ID: 20045954 [TBL] [Abstract][Full Text] [Related]
67. Cytokine signaling: STATS in plasma membrane rafts. Sehgal PB; Guo GG; Shah M; Kumar V; Patel K J Biol Chem; 2002 Apr; 277(14):12067-74. PubMed ID: 11815625 [TBL] [Abstract][Full Text] [Related]
68. STAT proteins as novel targets for cancer drug discovery. Turkson J Expert Opin Ther Targets; 2004 Oct; 8(5):409-22. PubMed ID: 15469392 [TBL] [Abstract][Full Text] [Related]
69. Control of gp130 expression by the mitogen-activated protein kinase ERK2. Bonito NA; Drechsler J; Stoecker S; Carmo CR; Seckl MJ; Hermanns HM; Costa-Pereira AP Oncogene; 2014 Apr; 33(17):2255-63. PubMed ID: 23686311 [TBL] [Abstract][Full Text] [Related]
70. Different associations of CD45 isoforms with STAT3, PKC and ERK regulate IL-6-induced proliferation in myeloma. Zheng X; Li AS; Zheng H; Zhao D; Guan D; Zou H PLoS One; 2015; 10(3):e0119780. PubMed ID: 25781885 [TBL] [Abstract][Full Text] [Related]
71. Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. Klampfer L Curr Cancer Drug Targets; 2006 Mar; 6(2):107-21. PubMed ID: 16529541 [TBL] [Abstract][Full Text] [Related]
72. STAT1 is phosphorylated and downregulated by the oncogenic tyrosine kinase NPM-ALK in ALK-positive anaplastic large-cell lymphoma. Wu C; Molavi O; Zhang H; Gupta N; Alshareef A; Bone KM; Gopal K; Wu F; Lewis JT; Douglas DN; Kneteman NM; Lai R Blood; 2015 Jul; 126(3):336-45. PubMed ID: 25921060 [TBL] [Abstract][Full Text] [Related]
73. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Yang J; Liao X; Agarwal MK; Barnes L; Auron PE; Stark GR Genes Dev; 2007 Jun; 21(11):1396-408. PubMed ID: 17510282 [TBL] [Abstract][Full Text] [Related]
74. Response to interferons and antibacterial innate immunity in the absence of tyrosine-phosphorylated STAT1. Majoros A; Platanitis E; Szappanos D; Cheon H; Vogl C; Shukla P; Stark GR; Sexl V; Schreiber R; Schindler C; Müller M; Decker T EMBO Rep; 2016 Mar; 17(3):367-82. PubMed ID: 26882544 [TBL] [Abstract][Full Text] [Related]
75. Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130. I. Definition of a novel phosphotyrosine motif mediating STAT1 activation. Gerhartz C; Heesel B; Sasse J; Hemmann U; Landgraf C; Schneider-Mergener J; Horn F; Heinrich PC; Graeve L J Biol Chem; 1996 May; 271(22):12991-8. PubMed ID: 8662591 [TBL] [Abstract][Full Text] [Related]
76. Mutations in the linker domain affect phospho-STAT3 function and suggest targets for interrupting STAT3 activity. Mertens C; Haripal B; Klinge S; Darnell JE Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14811-6. PubMed ID: 26553978 [TBL] [Abstract][Full Text] [Related]
77. Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like Response. Harwardt T; Lukas S; Zenger M; Reitberger T; Danzer D; Übner T; Munday DC; Nevels M; Paulus C PLoS Pathog; 2016 Jul; 12(7):e1005748. PubMed ID: 27387064 [TBL] [Abstract][Full Text] [Related]
78. EGFR induces expression of IRF-1 via STAT1 and STAT3 activation leading to growth arrest of human cancer cells. Andersen P; Pedersen MW; Woetmann A; Villingshøj M; Stockhausen MT; Odum N; Poulsen HS Int J Cancer; 2008 Jan; 122(2):342-9. PubMed ID: 17918184 [TBL] [Abstract][Full Text] [Related]
79. Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings. Pan CM; Wang ML; Chiou SH; Chen HY; Wu CW Oncotarget; 2016 Sep; 7(37):60395-60406. PubMed ID: 27486982 [TBL] [Abstract][Full Text] [Related]
80. Vitamin D decreases STAT phosphorylation and inflammatory cytokine output in T-LGL leukemia. Olson KC; Kulling PM; Olson TL; Tan SF; Rainbow RJ; Feith DJ; Loughran TP Cancer Biol Ther; 2017 May; 18(5):290-303. PubMed ID: 27715403 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]